EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advances in biomimetic nano delivery systems for pulmonary hypertension therapy

Pengtao Zhao, Min Wang, Ziwen Liu, Miaotiao Zhang, Zhigui Cai, Bo Zhang, Zhaoling Shi, Manling Liu, Ying Cheng

Acta Biomaterialia · 2026-02 · 211 · 266-287

DOI: 10.1016/j.actbio.2025.08.034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-02. Verfasst von Pengtao Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Sciences and Medicine, School of Medicine, Northwest University, 229 Taibai North Road, Xi'an 710069, Shaanxi, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Projects of Shaanxi Province, Key Science and Technology Program of Shaanxi Province, Education Department of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH), a condition triggered by various pathogenic factors, is characterized by a progressive increase in intra-pulmonary artery pressure and pulmonary resistance and progressive right ventricular hypertrophy, eventually culminating in right heart failure. Despite the fact that the conventional treatments can alleviate symptoms, they are limited by sub-optimal drug accumulation in the pulmonary vasculature and low bioavailability. Currently, as an emerging technology, the Nano Drug Delivery System (NDDS) has played a decisive role in enhancing drug targeting and precision and concomitantly minimizing side effects. This paper aims to summarize the pathophysiological mechanisms underlying PH and the knowledge related to the preparation and modification of cell-derived Biomimetic Nano Delivery Systems (BNDS), and to review the latest advancements in the application of BNDS for PH treatment, thereby laying a theoretical reference and offering novel insights for developing effective therapeutic strategies for PH. STATEMENT OF SIGNIFICANCE: Pulmonary hypertension (PH) remains a life-threatening cardiopulmonary disorder with limited therapeutic efficacy. While nanotechnology-based drug delivery systems hold promise for addressing these challenges, the emerging field of cell-derived biomimetic nanodelivery systems (BNDS) represents a groundbreaking shift toward intelligent, targeted, and biocompatible therapeutic strategies. This review not only synthesizes the pathophysiological underpinnings of PH and the design principles of BNDS but also critically evaluates their transformative potential in overcoming pulmonary vascular targeting barriers and improving therapeutic precision. By bridging cutting-edge advancements in biomimetic nanotechnology with PH pathophysiology, this work provides a comprehensive theoretical framework and innovative perspectives to inspire the development of next-generation therapies, ultimately paving the way for improved clinical outcomes and reduced mortality in PH patients.

Schlagwörter

Stichwörter der Autor:innen

Bionic membraneExosomes targeted deliveryNanotherapyPulmonary hypertension

Autor:innen und Institutionen

  • Faculty of Life Sciences and Medicine, School of Medicine, Northwest University, 229 Taibai North Road, Xi'an 710069, Shaanxi, China.
  • Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China.
  • Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Air Force Medical University, Xi'an 710032, Shaanxi, China.
  • Department of Pathology and Pathophysiology, Air Force Medical University, Xi'an 710032, Shaanxi, China.
  • The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China.
  • Department of Pathology and Pathophysiology, Air Force Medical University, Xi'an 710032, Shaanxi, China. Electronic address: manlingliu@fmmu.edu.cn.

Förderung

  • Key Research and Development Projects of Shaanxi Province
  • Key Science and Technology Program of Shaanxi Province
  • Education Department of Shaanxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, P., Wang, M., Liu, Z., Zhang, M., Cai, Z., Zhang, B., Shi, Z., Liu, M., & Cheng, Y. (2026). Advances in biomimetic nano delivery systems for pulmonary hypertension therapy. Acta Biomaterialia, 211, 266-287. https://doi.org/10.1016/j.actbio.2025.08.034

Vancouver

Zhao P, Wang M, Liu Z, Zhang M, Cai Z, Zhang B, et al. Advances in biomimetic nano delivery systems for pulmonary hypertension therapy. Acta Biomaterialia. 2026;211:266-287. doi:10.1016/j.actbio.2025.08.034

BibTeX
@article{Zhao2026,
  author = {Zhao, Pengtao and Wang, Min and Liu, Ziwen and Zhang, Miaotiao and Cai, Zhigui and Zhang, Bo and Shi, Zhaoling and Liu, Manling and Cheng, Ying},
  title = {Advances in biomimetic nano delivery systems for pulmonary hypertension therapy},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {211},
  pages = {266--287},
  doi = {10.1016/j.actbio.2025.08.034}
}
Kostenlos starten →